Acworth Pharmaceuticals, Inc. — Form D
Acworth Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-07. The offering totals $500K, of which $352K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-05-07
- Form: D
- Accession: 0001736361-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $352K
- Remaining: $148K
- Investors: 14
- Date of first sale: 2021-04-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-398646
Issuer
- Name: Acworth Pharmaceuticals, Inc.
- CIK: 0001736361
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: C/O LABCENTRAL, CAMBRIDGE, MA, 02139
- Phone: 617-529-0160
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Edward W Marple | Director | Cambridge, MA |
| Travis W Metz | Director | Cambridge, MA |
| Jack W Leonard | Executive Officer | Cambridge, MA |
| Edward W Marple | Executive Officer | Cambridge, MA |
| Jack W Leonard | Promoter | Cambridge, MA |
| Edward W Marple | Promoter | Cambridge, MA |
| Jack R Leonard | Executive Officer | Cambridge, MA |
| Jack R Leonard | Promoter | Cambridge, MA |
| Travis R Metz | Director | Cambridge, MA |
Other filings by this issuer (2)
More